Thank you Soroush, and good afternoon, everyone. I would like to start with a summary of our fourth quarter financial results. Revenue in the fourth quarter was $2.9 million, reflecting consistent progress we continued to make on customer development milestones. Non-GAAP operating loss was $25.7 million in the fourth quarter, driven primarily by R&D expenses related to product development and to a lesser extent, G&A and sales and marketing expenses. Growth cash use, which we define as operating cash flow less capital expenditure, was $26.6 million for the fourth quarter. As a result, our balance sheet remains strong with cash, cash equivalent and marketable securities totaling $445 million at the end of the fourth quarter. Finally, our weighted average shares outstanding in fourth quarter were $214.3 million. Turning to full year 2021 results, revenue was $9.3 million, representing 91% year-over-year growth. Non-GAAP operating loss was $81.9 million and growth cash use was $86 million, which is at the low end of the $85 million to $95 million range provided last year, demonstrating a continued discipline in how we invest for growth. Now on our financial outlook for 2022. We continue to progress towards production with all of our key partners and remain on track with their development milestones and timelines, while also pursuing opportunities with new customers. As Soroush mentioned, we are accelerating our path to commercialization. While strategically speeding our transition from NREs towards scale deployment of Aeries will reduce contribution from NREs in 2022, we believe this will enable us to begin scaling commercial programs with product sales revenues earlier than previously contemplated. As such, we expect revenue in 2022 to be in the range of $8 million to $12 million, representing and up to 30% year-over-year increase depending on the scaling of Aeries deployment. Based on the timeline of our customers' development milestones and the expected Aeries ramp, we expect revenue to be back end loaded in 2022. Turning to non-GAAP operating expense, which exclude stock-based compensation and other potential non-recurring charges, we expect this to be in the range of $140 million to $150 million in 2022, which primarily reflects our growing team and incremental investment in product development and initiatives to accelerate towards commercialization. In summary, the results in 2021 highlight our ability to execute all our plan to bring Aeva 4D LiDAR to market. And looking forward, we remain well-positioned with our balance sheet to continue investing to support our expanding number of customers and accelerated timeline towards commercialization. With that, I'll turn it over to Soroush for closing remarks.